Minerva Neurosciences, Inc.
Minerva Neurosciences to Report First Quarter 2017 Financial Results and Business Updates on May 4, 2017
Management to host conference call
WALTHAM, Mass., April 27, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2017 on Thursday, May 4, 2017. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates.
The live call may be accessed by dialing (877) 312-5845 for domestic callers or (765) 507-2618 for international callers and referring to conference ID number 2971783. A live webcast of the conference call will be available online in the Investors and Media section of the Company's website at ir.minervaneurosciences.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event for 30 days.
About Minerva Neurosciences
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat CNS diseases. Minerva's proprietary compounds include: MIN-101, in clinical development for schizophrenia; MIN-117, in clinical development for major depressive disorder (MDD); MIN-202 (JNJ-42847922), in clinical development for insomnia and MDD; and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV." For more information, please visit www.minervaneurosciences.com .
William B. Boni
VP, Investor Relations/
Minerva Neurosciences, Inc.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
VITEC18.1.2018 21:08 | pressemeddelelse
VITEC to Highlight EZ TV IPTV and Digital Signage Platform in First ISE Appearance
Brookfield Asset Management Inc18.1.2018 16:13 | pressemeddelelse
Brookfield Asset Management Notice of 2017 Year End Results Conference Call and Webcast
LifeSci Advisors, LLC18.1.2018 14:32 | pressemeddelelse
LifeSci Advisors Continues Expansion of U.S. Investor Relations Team with Appointment of Industry Veteran Monique Kosse
Cisco18.1.2018 14:02 | pressemeddelelse
FutureWAN'18 Brings Industry Leaders Together for Global SD-WAN Summit
Renaissance BioScience Corp.18.1.2018 13:01 | pressemeddelelse
Angel Yeast Co., Ltd. signs exclusive global licence agreement with Renaissance BioScience Corp. for wine, cider and craft beer yeast
JD Norman Industries, Inc.18.1.2018 06:02 | pressemeddelelse
JD Norman Industries, Inc. Completes Acquisition of REGE Motorenteile
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum